Main Line biopharma firm behind Covid-19 therapy raises $30M to advance product line
August 24, 2021 at 12:41 PM EDT
The Radnor company recently received its first regulatory approval for its Covid-19 treatment.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|